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Cellular responsiveness tomany neuromodulators is controlled by endocytosis of the transmembrane recep-
tors that transduce their effects. Endocytic membrane trafficking of particular neuromodulator receptors
exhibits remarkable diversity and specificity, determined largely by molecular sorting operations that guide
receptors at trafficking branchpoints after endocytosis. In this Review, we discuss recent progress in eluci-
dating mechanisms mediating the molecular sorting of neuromodulator receptors in the endocytic pathway.
There is emerging evidence that endocytic trafficking of neuromodulator receptors, in addition to influencing
longer-term cellular responsiveness under conditions of prolonged or repeated activation, may also affect
the acute response. Physiological and pathological consequences of defined receptor trafficking events
are only now being elucidated, but it is already apparent that endocytosis of neuromodulator receptors
has a significant impact on the actions of therapeutic drugs. The present data also suggest, conversely,
that mechanisms of receptor endocytosis and molecular sorting may themselves represent promising
targets for therapeutic manipulation.Introduction
The spatial and temporal actions of neuromodulators are
determined by local sensitivity of target neurons, and this is
fundamentally determined by mechanisms that control the
number and functional activity of cognate receptors that are
locally available for activation (Kenakin, 2004). These properties,
in turn, are subject to physiological regulation. Accordingly,
achieving appropriate neuromodulation requires dynamic and
local control of the number and activity of specific neuromodula-
tor receptors expressed in target neurons.
Most neuromodulator receptors belong to the seven-
transmembrane receptor (7TMR) family, also called G protein-
coupled receptors because many of their downstream effects
are transduced by activation of heterotrimeric guanosine
triphosphate (GTP)-binding proteins (G proteins). 7TMRs com-
prise the largest and most diverse family of signal-transducing
receptors, as reviewed elsewhere (Rosenbaum et al., 2009;
Gainetdinov et al., 2004). 7TMRs are typically subject to exqui-
site regulation by the coordinated actions of multiple mecha-
nisms (Gainetdinov et al., 2004; Jean-Alphonse and Hanyaloglu,
2011). One general class of 7TMR regulatory mechanisms is
through posttranslational modification. 7TMR modification by
phosphorylation, acylation, and ubiquitylation can produce
diverse effects on the ability of receptors to bind ligands and to
interact with various cytoplasmic mediator and regulator
proteins, as reviewed previously elsewhere (Gainetdinov et al.,
2004; Qanbar and Bouvier, 2003; Shenoy, 2007; Kirkin and Dikic,
2007). Another class of 7TMR regulatory mechanisms is through
physical movement, or trafficking, from onemembrane compart-
ment or subdomain to another. 7TMR membrane trafficking
modifies cellular signaling responsiveness by dynamically
altering the number of functional receptors available for activa-22 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.tion by neuromodulators in target neurons or in a particular
subcellular location of the neuron.
Even closely related 7TMR family members can differ mark-
edly in trafficking behaviors in both the biosynthetic and endo-
cytic pathways, as reviewed elsewhere (Jean-Alphonse and
Hanyaloglu, 2011; Sorkin and von Zastrow, 2009). For 7TMRs
that transduce neuromodulator effects, diversity and specificity
of membrane trafficking is perhaps most remarkable in the
endocytic pathway. The present Review focuses on how this
regulation is achieved and the functional consequences of
7TMR endocytic trafficking to the control of neuromodulator
responsiveness. In doing so, we shall focus on progress made
through study of two subclasses of neuromodulatory 7TMR
that have been characterized in considerable detail, catechol-
amine receptors and opioid neuropeptide receptors, and on
functional consequences manifest at the level of ‘‘conventional’’
7TMR signalingmediated by allosteric coupling to heterotrimeric
G proteins. The reader is directed to other reviews discussing
additional diversity in membrane trafficking properties observed
among various 7TMR family members (Tsao and von Zastrow,
2001; Wolfe and Trejo, 2007) and for information regarding
‘‘alternate’’ 7TMR signaling by G protein-independent mecha-
nisms such as arrestin-mediated scaffolding of downstream
signaling components (Rajagopal et al., 2010).
7TMR Endocytosis and Differential Effects of Drugs
The first step in the endocytic trafficking of a 7TMR is its removal
from the plasma membrane by packaging into an endocytic
vesicle. Mammalian cells express multiple endocytic mecha-
nisms (McMahon and Boucrot, 2011; Sandvig et al., 2011) that
individual 7TMRs can potentially engage (Tsao and von Zastrow,
2001;Wolfe and Trejo, 2007). Many neuromodulatory 7TMRs are
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and highly versatile endocytic machines capable of internalizing
a wide variety of membrane cargoes in addition to 7TMRs
(McMahon and Boucrot, 2011; Conner and Schmid, 2003). In
studies that have carefully examined the endocytic process,
7TMRs primarily undergo activation-induced accumulation in
previously formed CCPs and only rarely appear to initiate CCP
formation on their own; accordingly, a major determinant of
7TMR endocytic rate is the degree to which receptors concen-
trate in CCPs (Goodman et al., 1998; Puthenveedu and von
Zastrow, 2006; Krupnick et al., 1997; Kang et al., 2009).
For many neuromodulatory 7TMRs that undergo regulated
endocytosis via CCPs, receptor concentration in them is
stimulated by activation-induced phosphorylation of receptors
followed by phosphorylation-promoted association of recep-
tors with beta-arrestins, as reviewed previously elsewhere
(Goodman et al., 1998; Gainetdinov et al., 2004). Beta-arrestins
bind both to activated 7TMRs and to components of the CCP
(including clathrin heavy chain, the endocytic adaptor protein
AP-2, and phosphatidylinositol 4,5-bisphosphate), thereby
functioning as regulated endocytic adaptors (Goodman et al.,
1996; Laporte et al., 1999; Gaidarov et al., 1999). Beta-arrestins
can associate with CCPs after assembly of major structural
components has already occurred (Santini et al., 2000; Puthen-
veedu and von Zastrow, 2006), explaining how 7TMRs concen-
trate in CCPs after their formation and in the presence of other
endocytic cargoes. While there is presently no evidence for
7TMR packaging into specialized CCPs a priori, 7TMRs can
associate with pre-existing CCPs apparently in a cooperative
manner, producing a receptor-enriched CCP subset, and their
presence can influence the kinetics of subsequent CCP matura-
tion events. This appears to be a means by which some 7TMRs,
including beta-adrenergic catecholamine receptors (Puthen-
veedu and von Zastrow, 2006) and mu opioid neuropeptide
receptors (Henry et al., 2012), locally modify the properties of
their enclosing CCP after the fact. 7TMR clustering in previously
formed CCPs has been directly demonstrated in neurons (Yu
et al., 2010) but subsequent ‘‘customization’’ of CCP dynamics
by locally accumulated 7TMRs has been shown only in nonneu-
ral cell models, and its functional significance remains largely
unexplored in any system.
A number of 7TMRs undergo activation-induced internaliza-
tion in vivo, but much remains to be learned about the conditions
under which this occurs. Mu opioid neuropeptide receptors,
for example, have long been known to internalize robustly
throughout the brain and in spinal cord neurons after administra-
tion of certain opioid agonist drugs (Sternini et al., 1996; Keith
et al., 1998; Trafton et al., 2000; Haberstock-Debic et al.,
2003), but internalization elicited by endogenous neuropeptide
release occurs to a smaller degree (Trafton et al., 2000) or is
limited to particular brain regions (Mills et al., 2004). Regulated
endocytosis of endogenous D1 dopaminergic catecholamine
receptors has been clearly documented in the striatum after
administration of direct or indirect agonist drugs (Berthet et al.,
2009; Dumartin et al., 1998) and occurs in primates in some path-
ological conditions (Guigoni et al., 2007) and in transporter
mutant mice exhibiting abnormally elevated extracellular dopa-
mine concentration (Dumartin et al., 2000). However, it remainsunclear to what degree D1 receptor endocytosis occurs in any
brain region in response to truly physiological levels of neuromo-
dulator. Based on present mechanistic understanding, efficient
endocytosis of 7TMRs requires and is effectively driven by
receptor occupancy by agonist, suggesting that differences
observed in vivo correspond to quantitative differences in overall
receptor occupancy produced by endogenously released neuro-
modulator relative to drugs. Supporting this idea, 7TMR internal-
ization observed in vivo has been used successfully as a proxy
for estimating local 7TMR activation both by endogenous
ligands and drugs (Trafton et al., 2000; Mantyh et al., 1995).
An interesting related question is whether drugs can produce
different regulatory effects than endogenous neuromodulators
after binding to the same 7TMRs. Naturally produced neuromo-
dulators typically stimulate endocytosis of cognate 7TMRs after
promoting receptor activation, at least when examined in
cultured cell models. However, some drugs that activate the
same receptors differ significantly in endocytic effects, even
when applied at high concentration in such a controlled system.
For example, opioid neuropeptides stimulate rapid endocytosis
of mu opioid receptors, whereas some nonpeptide drugs, such
as morphine, do so considerably less strongly (Keith et al.,
1996, 1998; Sternini et al., 1996). A predictor of the endocytic
activity of a particular drug is its relative agonist efficacy as
estimated through traditional pharmacological analysis, with
more efficacious agonists stimulating endocytosis generally
more strongly than less efficacious drugs (McPherson et al.,
2010). The precise nature of this relationship remains unclear,
however, and this question goes to the larger issue of whether
drugs can produce different effects on neuromodulatory pro-
cesses than endogenous ligands. Early studies proposed the
existence of drug-specific receptor conformational states (Von
Zastrow et al., 1993; Keith et al., 1996), and subsequent studies
support the hypothesis that opioid ligand effects are not
adequately described by a single ‘‘dimension’’ of agonist activity
(Whistler et al., 1999; Borgland et al., 2003; Pradhan et al., 2010;
Arttamangkul et al., 2006). This concept remains controversial,
however, particularly with regard to understanding the effects
of morphine (McPherson et al., 2010; Molinari et al., 2010).
Nevertheless, the general idea that some drugs promote regu-
lated endocytosis of opioid receptors out of proportion to
conventional estimates of relative agonist activity is increasingly
recognized (Rivero et al., 2012).
Recent mechanistic data provide independent support for this
concept because opioid receptor engagement with arrestins and
subsequent clustering in CCPs, key initiating events affecting the
rate of agonist-induced endocytosis, require multisite phosphor-
ylation of the receptor’s cytoplasmic tail. Detailed analysis of
discrete phosphorylated receptor forms generated in intact cells,
by quantitative mass spectrometry applied to isotope-labeled
cells, indicates that this multisite requirement renders endocy-
tosis inherently nonlinear with respect to receptor activation
(Lau et al., 2011). This principle for generating nonlinearity by
multiphosphorylation is reminiscent of howmultiphosphorylation
can produce ‘‘ultrasensitive’’ responses in other biological
contexts (Nash et al., 2001; Ferrell, 1996) and is a particularly
attractive strategy for integral membrane proteins such as
7TMRs because significant nonlinearity can occur even in theNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 23
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Figure 1. Simplified Outline of Divergent 7TMR Endocytic
Membrane Traffic
Keymembrane compartments defining the endocytic pathway are indicated in
blue, and black arrows indicate main routes of endocytic membrane traffic
between compartments. Many 7TMRs (indicated as serpentine black line)
enter the endocytic pathway after ligand-induced activation by clustering in
CCPs. Molecular sorting operations occurring largely in early or sorting en-
dosomes guide receptor trafficking itinerary between divergent routes medi-
ating receptor delivery to late endosomes and then lysosomes (route A) or
back to the plasma membrane (route B). This is a key decision because 7TMR
trafficking to lysosomes results in proteolytic degradation (red arrow), while
recycling returns receptors intact to the plasma membrane (green arrow).
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et al., 2011). Accordingly, nonlinear control by multisite phos-
phorylation may underlie how apparently complex differences
in the regulatory effects of drugs—variously described in terms
of ‘‘functional selectivity,’’ ‘‘multidimensional’’ efficacy, or
‘‘agonist bias’’—are manifest at the cellular level.
7TMR Membrane Trafficking after Endocytosis
One function of 7TMR endocytosis is to initiate a multistep
trafficking pathway mediating receptor delivery to lysosomes,
a proteolytic organelle in which many 7TMRs are destroyed (Fig-
ure 1A). When a sufficient fraction of the overall cellular receptor
pool is depleted through this pathway, as can occur under condi-
tions of prolonged or repeated ligand-induced activation, cellular
signaling responsiveness to neuromodulator is attenuated or
‘‘downregulated’’ (Tsao et al., 2001). Endocytic downregulation
of delta opioid neuropeptide receptors by delivery to lysosomes,
first recognized in cultured neuroblastoma cells (Law et al.,
1984), has been directly shown in vivo and correlated with devel-
opment of physiological tolerance to opioid drugs (Pradhan
et al., 2009; Scherrer et al., 2006).
Individual 7TMRs differ greatly in the efficiency with which they
traffic to lysosomes after endocytosis, and this contributes to
receptor-specific differences in endocytic regulation (Tsao and
von Zastrow, 2000). Some 7TMRs appear to be remarkably
stable after endocytosis. Radioligand binding assays of mu
opioid receptors, for example, detect little downregulation in24 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.most brain regions even after prolonged administration of
agonist drugs (Sim-Selley et al., 2000; Yoburn et al., 1993).
Instead, it is thought that the major trafficking itinerary of
receptors after ligand-induced endocytosis is nondestructive
recycling to the plasma membrane, which can occur repeatedly
and efficiently under conditions of prolonged agonist exposure
(Tanowitz and von Zastrow, 2003) (Figure 1B). 7TMR recycling
has long been recognized to be one means for supporting the
ability of cells to sustain cellular responsiveness to a neuromodu-
lator or for achieving efficient recovery of responsiveness after
a period of functional desensitization (Gainetdinov et al., 2004).
An important caveat is that most studies investigating the func-
tional consequences of 7TMR recycling are limited to cultured
cell systems. However, the rapid recycling pathway traversed
by adrenergic catecholamine receptors is essential for maintain-
ing physiological catecholamine responsiveness of the heart
(Odley et al., 2004). Conversely, disrupting the ability of mu
opioid receptors to recycle efficiently in vivo produces enhanced
physiological tolerance to the antinociceptive effects of opioids
(Enquist et al., 2011).
Differences in the endocytic trafficking fate of otherwise
similar 7TMRs can confer essentially opposite functional effects
on longer-term cellular signaling responsiveness (Cao et al.,
1999; Tanowitz and von Zastrow, 2003). In principle, discrete
endocytic fates could be mediated by altogether different
endocytic mechanisms or bymolecular sorting of receptors after
endocytosis. The former possibility has not been fully ruled out
and may apply to the regulation of some 7TMRs. However, there
is compelling evidence that opioid and catecholamine receptors
are subject to exquisitely selective molecular sorting after endo-
cytosis by a shared, CCP-dependent early endocytic pathway
(Tsao and von Zastrow, 2000; Puthenveedu et al., 2010). The
following discussion will focus on such ‘‘postendocytic’’ sorting
of 7TMRs and the recycling-versus-degradation decision as
a relatively extensively studied example.
7TMR Sorting to Lysosomes
Many signaling receptors require ubiquitylation for endocytic
delivery to lysosomes and recycle efficiently to the plasma
membrane when their ubiquitylation is prevented (Raiborg and
Stenmark, 2009; Eden et al., 2012). Ubiquitin-directed sorting
is mediated by a complex endosome-associated machinery,
extensively conserved from yeast to humans, which is collec-
tively called the endosomal sorting complex required for trans-
port (ESCRT, Figure 2A). A great deal is presently known about
ESCRT structure and function, as discussed in excellent recent
reviews (Hurley and Hanson, 2010; Henne et al., 2011; Raiborg
and Stenmark, 2009). In brief, the ESCRT machinery associates
with the endosome-limiting membrane and functions both to (1)
generate intralumenal membrane vesicles within late endo-
somes and multivesicular bodies and (2) capture ubiquitylated
membrane proteins after endocytosis and direct their selective
packaging into intralumenal vesicles. Together, these events
prevent internalized receptors from recycling to the plasma
membrane and promote the subsequent delivery of ubiquitin-
marked receptors to lysosomes. Ubiquitin-directed sorting has
been extensively demonstrated in mammalian cells for the


























Figure 2. Multiple Sorting Machineries
Associated with the Endosome-Limiting
Membrane Cooperate in Determining the
Postendocytic Fate of 7TMRs
Ubiquitin attached to the cytoplasmic surface of
internalized 7TMRs (red circle) can engage the
‘‘endosomal sorting complex required for trans-
port’’ (ESCRT, box A), comprised of a set of
multiprotein complexes including HRS and
TSG101, which directly bind ubiquitinated recep-
tors, and VPS4, which mediates ATP-dependent
disassembly of the ESCRT complex and is
required for efficient formation of membrane
vesicles within the endosome lumen (blue circle
within endosome). ESCRT-dependent transfer of
ubiquitinated receptors from the endosome-
limiting membrane to intralumenal vesicles
effectively prevents receptors from entering the
recycling pathway and enhances the accessibility
of receptors to proteases after fusion of 7TMR-
containing endocytic vesicles with lysosomes. A
variety of proteins are proposed to interact with
internalized 7TMRs in the endosome-limiting
membrane, effectively tethering them away from
traversing the recycling pathway with bulk
membrane flux (box B). Recycling sequences
present in the 7TMR cytoplasmic surface (green
cone) engage a discrete machinery associated
with the endosome-limiting membrane (box C),
which prevents receptors from trafficking to lysosomes and actively promotes their recycling via membrane tubules that pinch off from endosomes and later fuse
with the plasma membrane. Main components of the ‘‘actin-sorting nexin 27-retromer’’ (ASRT) complex that mediates PDZ motif-directed recycling of 7TMRs
such as beta-adrenergic receptors are diagrammed.
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evidence for ubiquitin-directed sorting of various 7TMRs, as
reviewed elsewhere (Marchese et al., 2008; Shenoy, 2007; Kirkin
and Dikic, 2007). In some cases, specific ubiquitin ligases and
hydrolases controlling 7TMR endocytic trafficking have been
identified, as previously reviewed elsewhere (Hislop and von
Zastrow, 2011; Marchese et al., 2008; Shenoy, 2007), but the
available information on this topic is presently limited to studies
of 7TMR regulation in nonneural cell types.
Some neuromodulatory 7TMRs do not require ubiquitylation to
undergo efficient endocytic delivery to lysosomes, and there is
evidence for additional machinery directing this process. For
example, internalized delta opioid receptors can be effectively
excluded from the recycling pathway and delivered to lyso-
somes even when their ubiquitylation is prevented by mutation
of all cytoplasmic lysine residues (Tanowitz and Von Zastrow,
2002). Receptor ubiquitylation enhances but is not required for
opioid receptor localization to intralumenal vesicles, and recep-
tors can be delivered to lysosomes for inactivating proteolytic
fragmentation even when transfer to intralumenal vesicles is
blocked (Hislop et al., 2009; Henry et al., 2011). Nevertheless,
irrespective of whether or not ubiquitylation of receptors is
allowed to occur, the overall process of delta opioid receptor
degradation requires the main components of the ESCRT
machinery (Hislop et al., 2004). Accordingly, the present data
suggest that discrete ubiquitin-independent and -dependent
sorting mechanisms operate in series in the conserved
ESCRT-dependent MVB pathway, with the ubiquitylation-
independent mechanism operating effectively upstream and
having the ability to effectively ‘‘force’’ internalized receptors to
traffic to lysosomes even when their ubiquitylation is prevented
(Henry et al., 2011). Evidence for ubiquitylation-independentsorting of internalized 7TMRs to lysosomes, as for the ubiqui-
tin-directed sorting mechanism discussed above, is presently
limited primarily to studies of nonneural cell types.
The biochemical basis for ubiquitylation-independent lyso-
somal delivery of 7TMRs remains poorly understood in any
system. One possibility is that internalized receptors are guided
to lysosomes simply through ‘‘piggybacking’’ on a ubiquitin-
directed cargo, as proposed for ubiquitin-independent traf-
ficking in yeast (Macdonald et al., 2011), but this seems unlikely
for delta opioid receptors because of the above-noted differ-
ences in basic features of receptor downregulation. Another
possibility is that there exists additional machinery directing
some 7TMRs to lysosomes (Figure 2B). Early studies identified
a cytoplasmic protein that binds the cytoplasmic tail of delta
opioid receptors irrespective of ubiquitylation and is highly
expressed in the brain (Whistler et al., 2002). Overproducing a
C-terminal fragment in transfected fibroblastic cells inhibited
ligand-induced downregulation of coexpressed delta opioid
receptors, leading to the suggestion that this protein represents
a putative ‘‘G protein-coupled receptor-associated sorting
protein’’ (GASP). A family of related GASP proteins (now called
GPRASPs) was subsequently identified, which are widely
expressed in mammals but not in yeast (Abu-Helo and Simonin,
2010). Supporting the potential in vivo significance of this mech-
anism in neurons, genetic knockout of the originally identified
GASP protein (GPRASP1) in mice blocked cocaine-induced
downregulation of D2 dopamine receptors in the brain (Thomp-
son et al., 2010). Independent biochemical studies suggested
that GPRASPs provide alternate connectivity of internalized
receptors to the ESCRT machinery (Marley and von Zastrow,
2010), potentially explaining enhanced recycling of D2 dopamine
receptors observed in the cortex of dysbindin knockout miceNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 25
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unclear, however, and other studies have suggested distinct or
additional roles in 7TMR sorting or signaling (Abu-Helo and
Simonin, 2010). There is also evidence that additional protein
interactions engaged by 7TMRs, including conventional beta-
arrestins as well as so-called alpha-arrestins that are thought
to share structural features, may prevent internalized 7TMRs
from exiting endosomes or provide alternate connectivity of
receptors to the ubiquitylation/ESCRT machinery (Shenoy
et al., 2009; Nabhan et al., 2010). Moreover, Rab family small
GTP-binding proteins, long known to be master regulators of
both the biosynthetic and endocytic pathways, have been
observed to affect the endocytic sorting of particular 7TMRs
through direct interaction (Seachrist and Ferguson, 2003; Essel-
tine et al., 2011). Endocytic trafficking effects have been re-
ported for direct 7TMR interaction with several Rab family
members (Rabs 4, 8, and 11) but, to our knowledge, all of the
evidence regarding a discrete tethering function of Rabs is
presently limited to 7TMR trafficking in nonneural cells.
7TMR Recycling to the Plasma Membrane
Another clue to the existence of additional, ubiquitylation-inde-
pendent endocytic sorting machinery relevant to neuromodula-
tory 7TMR regulation is that efficient recycling of some 7TMRs
requires a discrete cytoplasmic sorting determinant that can
clearly operate irrespective of receptor ubiquitylation. Beta-
adrenergic receptors, for example, require a PDZ domain-
interacting sequence for efficient plasma membrane recycling
in both fibroblasts (Cao et al., 1999) and neurons (Yudowski
et al., 2006; Yu et al., 2010), and the sorting activity of this
sequence does not require cytoplasmic lysine residues that
represent potential sites of receptor ubiquitylation (Hanyaloglu
and von Zastrow, 2007). A variety of such ‘‘recycling sequences’’
have been identified in other 7TMRs, but not all are PDZ motifs.
An interesting example is the mu opioid receptor, whose recy-
cling is promoted by a discrete, PDZ-independent C-terminal
sequence that is devoid of lysine residues and critically depends
on two leucine residues separated by two other amino acids
(L-x-x-L) (Yu et al., 2010; Tanowitz and von Zastrow, 2003).
This system of endocytic fate determination confers additional
regulation and diversity of 7TMR regulation. For example, phos-
phorylation of the PDZ motif present in the beta-adrenergic
receptor tail blocks its recycling activity and results in flexible
rerouting of internalized beta-adrenergic receptors to the lyso-
somal downregulation pathway (Cao et al., 1999). Alternative
splicing of mu opioid receptor transcripts creates variant recep-
tors that lack the ‘‘L-x-x-L’’ recycling sequence and thus prefer-
entially downregulate rather than recycle after endocytosis
(Tanowitz et al., 2008). Both PDZ-dependent sequences derived
from beta-adrenergic receptors and the discrete PDZ-indepen-
dent sequence derived from mu opioid receptors have been
explicitly shown to promote efficient sorting of internalized
7TMRs into the recycling pathway in neurons (Yu et al., 2010).
The biochemical machinery that mediates sequence-directed
recycling has only recently begun to come into focus, based
largely on study of PDZ motif-directed recycling of beta-
adrenergic receptors (Figure 2C). The critical trans-acting protein
recognizing the recycling sequence present in the adrenergic26 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.receptor cytoplasmic tail is sorting nexin 27 (SNX27) (Lauffer
et al., 2010). Sorting nexins comprise a diverse family of
cytoplasmic proteins that share a phosphoinositide-binding
‘‘SNX-PX’’ domain linking them to endosome and/or plasma
membranes, and members of the sorting nexin family are found
in diverse organisms (Worby and Dixon, 2002; Carlton et al.,
2005). SNX27, an early endosome-associating sorting nexin
that is the only known family member to possess a PDZ
domain, is restricted to metazoans. Depleting SNX27 inhibits
recycling of both the beta 1 and beta 2 adrenergic receptors
and increases receptor delivery to lysosomes, effectively pheno-
copying mutation of the respective C-terminal recycling
sequences. SNX27 is highly expressed in neurons and its
expression is subject to robust regulation by psychostimulant
drugs (Kajii et al., 2003). Accordingly, mechanistic elucidation
of the sequence-directed recycling machinery suggests the
existence of still more flexibility in the control of neuromodulatory
7TMR trafficking in vivo.
SNX27 acts as an adaptor to deliver internalized adrenergic
receptors to a multiprotein sorting machinery assembled at the
base of tubular extensions of the endosome-limiting membrane.
These tubules were initially recognized in live cell imaging as
sites associated with a dynamic Arp2/3-dependent actin
network, and from which internalized beta-adrenergic receptors
exit endosomes for return to the plasma membrane (Puthen-
veedu et al., 2010). These tubules were then found to associate
also with the retromer complex, a multiprotein complex previ-
ously known to function in endosome-to-Golgi delivery of
selected membrane cargoes (Bonifacino and Hurley, 2008),
and studies of adrenergic receptor recycling revealed an
additional role of the retromer complex in supporting ‘‘direct’’
endosome-to-plasma membrane delivery (Temkin et al., 2011).
SNX27 appears to associate both with the actin polymerization
machinery and with the retromer complex through an additional
multiprotein complex, the WASH complex (Temkin et al., 2011),
which regulates Arp2/3-mediated actin nucleation and associ-
ates with the retromer complex at the base of endosome tubules
(Gomez and Billadeau, 2009). Together, these findings led to
the identification of an ‘‘actin-SNX27-retromer tubule’’ (ASRT)
interaction network, which represents a discrete sorting
machinery directing specific 7TMRs from the endosome-limiting
membrane into the rapid recycling pathway (Figure 2C). The
range of endocytic cargoes that are sorted by the ASRT
machinery remains to be determined, and ASRT function in
neurons is only beginning to be explored. However, PDZ motif-
directed recycling clearly occurs in neurons, as noted above,
and all known components of the ASRTmachinery are highly ex-
pressed in the brain.
Trans-acting Sorting Effects
The discussion up to now would suggest that 7TMRs are
sorted completely independently of one another. While there is
indeed remarkable specificity in the endocytic itinerary of even
closely related 7TMRs, and this is apparent even when homolo-
gous receptors are coexpressed at supraphysiological levels,
accumulating evidence points to the ability of some neuromodu-
latory 7TMRs to influence the trafficking properties of others
in trans.
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is through physical oligomerization of receptors. There is now
abundant evidence that 7TMRs can form homotypic and
heterotypic interactions, although the functional significance of
oligomer formation remains unclear for many 7TMRs (Milligan
and Bouvier, 2005). Briefly summarized, some 7TMRs (such as
GABA-B and metabotropic glutamate receptors) assemble
during or shortly after biosynthesis into a stable heterodimer
that is essential for biological activity, and these core hetero-
dimers may subsequently assemble into higher-order oligomers
(Kniazeff et al., 2011). For other 7TMRs, and probably for the
majority, oligomer formation is more variable and can occur
transiently, with receptors maintaining functional competence
as monomers (Whorton et al., 2007) and rapidly converting
between monomeric and oligomeric forms (Hern et al., 2010;
Kasai et al., 2011).
Much remains to be learned about biophysical and physiolog-
ical aspects of 7TMR oligomer formation, but there has been
evidence for many years supporting a role in receptor membrane
traffic. Studies of the Ste2p mating pheromone 7TMR in yeast
showed that an endocytic defect of a mutant Ste2p construct
was rescued in trans by expression of wild-type Ste2p, suggest-
ing that one 7TMR can physically ‘‘drag’’ another into the endo-
cytic pathway by oligomer formation (Overton and Blumer,
2000). Similar trans-effects have been widely observed in the
regulated endocytosis of mammalian 7TMRs, including opioid
neuropeptide receptors in native neurons (He et al., 2002), and
there is evidence from study of nonneural cell models that olig-
omer formation can affect the regulatory trafficking of 7TMRs
after endocytosis (Cao et al., 2005). Given extensive and growing
evidence that 7TMRs can form oligomers and that such interac-
tions can affect endocytic trafficking, the ability of coexpressed
receptors to sort in a receptor-specific manner is even more
remarkable. An interesting question that remains unexplored is
how 7TMR oligomerization is controlled to produce trans-effects
on some trafficking decisions while allowing other trafficking
decisions to occur independently.
A distinct type of 7TMR trans-regulation was discovered
serendipitously in nonneural cells, based on the observation
that simultaneous activation of the V2 vasopressin receptor
can inhibit agonist-induced endocytosis of other coexpressed
7TMRs including adrenergic and opioid receptors (Klein et al.,
2001). The mechanism turned out to involve V2 receptor-medi-
ated sequestration of the available cellular pool of beta-arrestins
to endosomes, based on persistent phosphorylation of recep-
tors that renders their affinity for arrestins unusually high (Oakley
et al., 2000). Verifying this, overexpressing beta-arrestins or
mutating phosphorylation sites in the V2 receptor cytoplasmic
tail to reduce arrestin binding blocked the trans-inhibition effect
and effectively rescued agonist-induced endocytosis of the
coexpressed 7TMRs (Klein et al., 2001). Subsequent studies
established similar mechanisms of trans-inhibition in native
neurons expressing the following relevant neuromodulatory
7TMRcombinations at endogenous levels: (1) NK1 andNK3 neu-
rokinin receptors in myenteric neurons (Schmidlin et al., 2002)
and (2) NK1 and mu opioid receptors both in medium spiny
neurons cultured from amygdala and in locus coeruleus neurons
examined in an acute brain slice preparation (Yu et al., 2009). Forboth 7TMR pairs, endocytic inhibition was associated with
impaired desensitization of a corresponding receptor-linked
downstream signaling response. It remains to be determined
how widespread this mechanism of trans-regulation is among
neuromodulator receptors, and what functional consequences
it produces in vivo. Based on first principles, one might expect
such trans-regulation to be quite widespread, particularly in
neuronal subcompartments such as dendrites and axons where
the locally available pool of arrestins is likely to be restricted.
Signaling Consequences of 7TMR Endocytosis
It is traditionally thought that 7TMR endocytosis regulates
cellular responsiveness to prolonged or repeated exposure to
neuromodulator (Figure 1), and there is increasingly strong
support for this hypothesis in vivo. Recent studies of delta opioid
receptor regulation provide a clear example. A green fluorescent
protein (GFP)-tagged delta opioid receptor, expressed at near-
endogenous levels in mutant mice, exhibited agonist-induced
endocytosis and was subsequently delivered to lysosomes in
CNS-derived neurons (Scherrer et al., 2006). Interestingly, the
occurrence of this trafficking process correlated temporally
with the development of physiological tolerance to subsequent
antinociceptive effects of the drug (Pradhan et al., 2009). A
different agonist drug, which does not strongly promote receptor
endocytosis, failed to elicit this component of physiological
tolerance but both drugs elicited a slower form of tolerance,
apparently through endocytosis-independent downstream
adaptation(s) (Pradhan et al., 2010). These results, in addition
to demonstrating a role of endocytic trafficking in attenuating
physiological opioid responsiveness, elegantly illustrate the
existence of discrete ‘‘layers’’ of homeostatic control impacting
tissue responsiveness to a neuromodulator over different time
scales.
Other studies of opioid receptor regulation suggest still more
complexity across receptors and systems. Agonist-induced
endocytosis of an epitope-tagged mu opioid receptor, ex-
pressed at near-endogenous levels in the locus coeruleus of
mutant mice, was visualized in acute brain slices by two-photon
fluorescence microscopy. Rapid endocytosis of receptors
occurred after application of several opioid agonists, but not
after application of even high concentrations of morphine
(Arttamangkul et al., 2008). However, morphine was able to
produce desensitization of the acute signaling response.
Further, previous studies from the same group showed that
blocking endocytosis of endogenous mu opioid receptors did
not impair enkephalin-induced desensitization of signaling, nor
did it detectably affect recovery from desensitization after
washout of the opioid peptide (Arttamangkul et al., 2006).
Thus, it appears that receptor endocytosis is not essential for
rapid functional desensitization or recovery from desensitization,
even after receptor activation by an agonist that robustly
promotes endocytosis over a similar time scale.
Interestingly, when animals were rendered opioid tolerant by
repeated administration of morphine prior to preparation of the
brain slice, rapid desensitization of the enkephalin-induced
electrophysiological response still occurred but its recovery after
agonist washout was inhibited (Quillinan et al., 2011). Chemical
inhibition of GRK2, a kinase that can promote mu opioidNeuron 76, October 4, 2012 ª2012 Elsevier Inc. 27
Figure 3. Proposed Subcellular Locations of
D1 Dopamine Receptor-Mediated Signaling
It has long been known that D1-type dopamine
receptors (blue) mediate acute cAMP signaling
through activating Gs/Golf heterotrimeric G pro-
teins (green) in the plasmamembrane (gray line, as
indicated). Recent evidence, as discussed in the
text, suggests that D1 receptors may also mediate
acute G protein activation from endosomes,
resulting in receptor-elicited cAMP production
from both the plasma membrane and endosome
membrane (yellow). Figure is adapted from
Kotowski et al. (2011).
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receptor’s cytoplasmic tail, produced a rapid recovery from
desensitization similar to that observed in brain slices prepared
from drug-naive animals. These results suggest that regulated
endocytosis of mu opioid receptors functions as a discrete,
second mechanism of functional desensitization that is engaged
under conditions of excessively prolonged neuromodulator
receptor activation, such as that produced by chronic drug
administration.
An intriguing additional observation made in the same study
(Quillinan et al., 2011) was that the GRK2-dependent component
of persistent desensitization occurred only in brain slices
prepared from animals rendered opioid tolerant with morphine,
but not from animals rendered tolerant with methadone. One
possible explanation for this difference could be that methadone
simply produced less tolerance in these experiments, but this
was not evident by behavioral assessment. Another possibility
is that the secondary form of opioid desensitization is drug
specific, engaged by morphine but not by drugs such as
methadone that promote endocytosis of mu opioid receptors
relatively robustly. If this is the case, further investigation
could identify a rational basis for improving the therapeutic
efficacy of opioid drugs. For example, one might expect
pharmacological manipulations that increase receptor endocy-
tosis (and subsequent recycling) to lessen the development of
physiological tolerance after prolonged or repeated drug
administration. Further, based on what is presently known about
delta opioid receptor regulation in vivo, one might expect manip-
ulations that increase lysosomal delivery of internalized recep-
tors to enhance or accelerate the development of physiological
tolerance.
Another interesting horizon in the relationship between neuro-
modulator receptor trafficking and function regards the effect of
receptor endocytosis on the acute signaling response. As
discussed above, it is generally believed that 7TMRs are func-
tionally uncoupled from G proteins before endocytosis and
remain unable to elicit ‘‘classical’’ G protein-linked signaling until
after reinsertion to the plasmamembrane by recycling. This view
is being reevaluated based on live cell imaging data indicating
that agonist-induced endocytosis of some 7TMRs, such as the
D1 dopaminergic catecholamine receptor, occurs remarkably28 Neuron 76, October 4, 2012 ª2012 Elsevier Inc.rapidly and on a similar time scale as the
acute biochemical signaling response.
Further, experimental manipulations that
impair D1 receptor endocytosis reducethe rate of initial cAMP accumulation detected in cells after acute
agonist application and also inhibit the ability of a D1-specific
agonist to produce a cAMP-dependent enhancement of
neuronal excitability in a brain slice preparation (Kotowski
et al., 2011). The mechanistic basis for this endocytosis-depen-
dent enhancement of acute D1 receptor-mediated signaling
remains incompletely understood, but a simple hypothesis is
that D1 receptors activate adenylyl cyclase both from the plasma
membrane and endosomes (Figure 3). This is plausible because
both heterotrimeric G proteins and adenylyl cyclases have been
detected on endosomes and there is evidence that endosomes
may contribute to a noncanonical mechanism of prolonged
7TMR signaling (Calebiro et al., 2009; Vilardaga et al., 2012).
However, it has not been directly determined whether or not
internalized 7TMRs can indeed elicit a ‘‘conventional’’ mode of
acute G protein-linked signaling from the endosome membrane.
Conclusion and Future Perspectives
This Review attempts to summarize the present understanding
of mechanisms and functional consequences of endocytic
membrane trafficking of neuromodulatory 7TMRs, focusing on
catecholamine and opioid neuropeptide receptors as important
and relatively well characterized examples. There has been
significant recent progress in understanding molecular sorting
operations that determine the membrane trafficking itinerary of
these 7TMRs after entry to the endocytic pathway. Much
remains unknown about the mechanistic basis of 7TMR sorting,
particularly ubiquitylation-independent trafficking to lysosomes
and the role of cytoskeletal dynamics in sequence-directed recy-
cling, and little is known about the operation of any specific
7TMR sorting mechanism in neurons.
One particularly interesting area for future study concerns the
organization of specific 7TMR trafficking mechanisms with
respect to the highly differentiated and polarized architecture
of neurons. There is already evidence for enhanced endocytosis
of opioid receptors in dendrites after systemic administration of
opioid drugs (Haberstock-Debic et al., 2003) and for reduced
functional desensitization of various 7TMRs including opioid
receptors in presynaptic relative to postsynaptic compartments
(Wetherington and Lambert, 2002; Pennock et al., 2012).
However, much remains to be learned about how 7TMR
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Reviewregulatory machineries are compartmentalized in neurons, and if
there are differences in the regulated endocytic trafficking of
receptors produced by local compared to global receptor
activation. Related to this is the question of which membrane
domain(s) are the source of physiologically salient 7TMR
signaling. The traditional view is that G protein-linked signaling
is restricted to the plasma membrane and based on rapid diffu-
sion of downstream mediators. However, it is increasingly clear
that even classical ‘‘diffusible’’ mediators such as cAMP are
spatially restricted through local synthesis and destruction
(Willoughby et al., 2006), and neuromodulators such as opioid
neuropeptides exhibit a limited range of action in neural tissue
(Banghart and Sabatini, 2012). Accordingly, the precise sub-
cellular location of 7TMR activation is likely to be an important
parameter in neuromodulation, particularly for projection
neurons and neurons with extensive dendritic arbors. Better
understanding of the compartmentation of 7TMR trafficking
and signaling will surely add to our understanding of the basic
physiology of endogenous neuromodulation and may provide
useful insight to how systemically administered drugs differen-
tially impact the function of neural circuits.
Additional questions arise from the observation that some
7TMRs affect one another’s endocytic regulation in trans, either
by direct physical interaction or through alternative mechanisms
such as depletion of the local pool of functional arrestin. We are
only at the beginning of investigating the functional conse-
quences of such trans-regulatory effects in vivo. Whereas mech-
anistic studies of 7TMR biology generally investigate the effects
of activating a single 7TMR or receptor class in isolation, it is
increasingly recognized that CNS neurons typically coexpress
multiple distinct types of neuromodulatory 7TMR (Bartfai et al.,
2012). Thus, trans-regulatory effects on 7TMR trafficking might
be a widespread but previously overlooked phenomenon in vivo,
with potentially major implications both to physiology and for
understanding drug effects on neuromodulation.
It is clear that endocytic membrane trafficking of endogenous
neuromodulatory 7TMRs occurs after exogenous administration
of agonist drugs and in some pathological states, but it remains
largely unresolved whether endocytic trafficking of 7TMRs
also represents a significant regulatory process under condi-
tions of normal physiological activation by endogenous neuro-
modulators. Future investigation of this question could provide
important insight to the pathological basis of neuropsychiatric
disease and guide the search for improved therapeutics
to manage complex disorders, such as mood and anxiety
syndromes, in which disturbed neuromodulatory tone is a prom-
inent feature.
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